Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-08-08
2006-08-08
Schultz, James (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S006120, C435S325000, C435S375000, C536S023100, C536S024500
Reexamination Certificate
active
07087584
ABSTRACT:
Disclosed are diagnostic and prognostic kits for the detection and treatment of proliferative diseases such as ovarian cancer, breast cancer, and lymphoma. Also disclosed are cancer therapeutics utilizing IAP antisense nucleic acids IAP fragments, and antibodies which specifically bind IAP polypeptides.
REFERENCES:
patent: 5834216 (1998-11-01), Roizman et al.
patent: 6187557 (2001-02-01), Rothe et al.
patent: WO 94/06814 (1994-03-01), None
patent: WO 95/19431 (1995-07-01), None
patent: WO 95/28497 (1995-10-01), None
patent: WO 96/12016 (1996-04-01), None
patent: WO 97/06182 (1997-02-01), None
patent: WO 97/06255 (1997-02-01), None
patent: WO 97/26331 (1997-07-01), None
patent: WO 98/22131 (1998-05-01), None
Jen et al. (Stem Cells, vol. 18: 307-319, 2000).
C. A. Stein. Is irrelevant cleavage the price of antisense efficacy? Pharmacology & Therapeutics vol. 85, pp. 231-236, 2000.
Chirila et al. The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides. Biomaterials, vol. 23, pp. 321-342, (2002).
Tamm I, Dorken B, and Hartmann G. “Antisense therapy in oncology: new hope for an old idea?”, The Lancet, Aug. 11, 2001, (358) pp. 489-497.
Braasch D and Corey D. “Novel Antisense and Peptide Nucleic Acid Strategies for Controlling Gene Expression”, Biochemistry, Apr. 9, 2002, (41)14 pp. 4503-4509.
Birnbaum et al., “An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs,”J. Virol., 68:2521, (1994).
Branch, “A good antisense molecule is hard to find,”TIBS, vol. 23, p. 45, (1998).
Campbell, Monoclonal Antibody Technology, Elsevier Science, Publishers B.V. New York, NY , (1984).
Cheng et al., “Staurosporine, K-252a, and K-252b Stabilize Calcuim Homeostasis and Promote Survival of CNS Neurons in the Absence of Glucose,”J. Neurochem., 62:1319, (1994).
Clem et al., “Anti-apoptotic genes of baculovirus,”Cell Death Different., 3:9, (1996).
Clem et al., “Induction and inhibition of apoptosis by insect viruses,” Apoptosis II: The Molecular Basis of Apoptosis in Disease, Cold Spring Harbor Laboratory Press, p. 89, (1994).
Clem et al., “Prevention of apoptosis by a baculovirus gene during infection of insect cells,”Science254:1388, (1991).
Clem et al., “Control of programmed cell death by the baculovirus genes p35 and IAP,”Mol. Cell Biol., 14:5212, (1994).
Crocker et al., “Adenovirus-mediated NAIP overexpression confers protection against global ischemia,”Soc. Neurosci. Abstr., 464.18, (1996).
Crook et al., “An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif,”J. Virol., 67:2168, (1993).
Dhein et al., “Autocrine T-cells suicide mediated by APO-1 (Fas/CD95),”Nature, 373:438, (1995).
Duckett et al., “A conserved family of cellular genes related to the baculovirus IAP gene and encoding apoptosis inhibitors,”EMBO J., 15:2685, (1996).
Fernandez et al., “Differential sensitivity of normal and ha-ras-transformed c3h mouse embryo fibroblasts to tumor necrosis factor: induction ofbcl-2, c-myc, and manganese superoxide dismutase in resistant cells,”Oncogene, 9:2009, (1994).
Ferrari et al., “N-acetylcysteine (D- and L-stereoisomers) prevents apoptotic death of neuronal cells,”J. Neurosci., 15:2857, (1995).
Fisher et al., “Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome,”Cell, 81:935, (1995).
Francis et al., “The response of GABAergic and cholinergic neurons to Transient Cerebral Ischemia,”Brain Res., 243:271, (1982).
Gibellini et al., “Tat-expressing Jurkat cells show an increased resistance to different apoptic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection,”Br. J. Haematol., 89:24, (1995).
Glicksman et al., “K-252a and staurosporing promote choline acetyltransferase activity in rat spinal cord cultures,”J. Neurochem., 61:210, (1993).
Glicksman et al., “K-252a analog prevents developmentally programmed motoneuron death and the loss of chat activity in adult motoneuronsin vivo,”Soc. Neurosci. Abstr., 441, (1994).
Glicksman et al., “K-252a promotes survival and choline acetyltransferase activity in striatal and basal forebrain neuronal cultures,”J. Neurochem., 64:1502, (1995).
Golstein et al., “Homology between reaper and the cell death domains of Fas and TNFR1,”Cell, 81:185, (1995).
Goruppi et al., “Dissection of c-myc domains involved in S phase induction of NIH3T3 fibroblasts,”Oncogene, 9:1537, (1994).
Harrington et al., “c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines,”EMBO J., 13:3286, (1994).
Itoh et al., “A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen,”J. Biol. Chem., 268:10932, (1993).
Katsikis et al., “Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals,”J. Exp. Med., 18:2029, (1995).
Kerr, “Neglected opportunities in apoptosis research,”Trends Cell Biol., 5:55, (1995).
Korsmeyer, “Regulators of cell death,”TIGS, 11:101, (1995).
Li et al., “Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein,”Science, 268:429, (1995).
Liston et al., “Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes,”Nature, 397:349, (1996).
Martin et al., “HIV-1 infection of human CD4+T cellsin vitro. Differential induction of apoptosis in these cells,”J. Immunol., 152:330, (1994).
Melino et al., “Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells,”Mol. Cell Biol., 14:6584, (1994).
Murayama et al., “Immunocytochemical and ultrastructural studies of Werdnig-Hoffmann disease,”Acta Neuropathol., 81:408, (1991).
Muro-Cacho et al., “Analysis of apoptosis in lymph nodes of HIV-infected persons: Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden,”J. Immunol., 154:5555, (1995).
Nakanshi et al., “K-252a, a novel microbial product, inhibits smooth muscle myosin light chain kinase,”J. Biol. Chem., 23:6215, (1988).
Nunez et al., “The Bcl-2 family of proteins: regulators of cell death and survival,”Trends Cell Biol., 4:399, (1994).
Osborne et al., “Essential genes that regulate apoptosis,”Trends Cell Biol., 4:394, (1994).
Peterson et al., “Loss of GABAergic neurons in medial septum after fimbria-fornix transection,”Neurosci. Lett., 76:140, (1987).
Pulsinelli et al., “Temporal profile of neuronal damage in a model of transient forebrain ischemia,”Ann. Neurol., 11:491, (1982).
Rabizadeh et al., “Expression of the baculovirus p35 gene inhibits mammalian neural cell death,”J. Neurochem., 61:2318, (1993).
Ridoux et al., “The use of adenovirus vectors for intracerebral grafting of transfected nervous cells,”Neuroreport, 5:801-804, (1994).
Ridoux et al., “Adenoviral vectors as functional retrograde neuronal tracers,”Brain Res., 648:171-175, (1994).
Ridoux et al., “Ex vivo culture of adult microglial cells from previously lesioned rat brains,”C.R. Acad. Sci. III, 317:217, (1994).
Rieux-Laucat et al., “Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity,”Science, 268:1347, (1995).
Robertson et al., “Neuroprotective effects of K252a in cerebral ischemia: The NAIP connection,”Soc. Neurosci. Abstr., 654.8, (1996).
Rosenbaum et al., “Evidence for hypoxia-induced, programmed cell death of cultured neurons,”Ann. Neurol., 36:864, (1994).
Rothe et al., “The
Baird Stephen
Korneluk Robert G.
Liston Peter
Mackenzie Alexander E.
Pratt Christine
Aegera Therapeutics Inc.
Bieker-Brady Kristina
Clark & Elbing LLP
Schultz James
LandOfFree
Detection and modulation of IAPs and NAIP for the diagnosis... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection and modulation of IAPs and NAIP for the diagnosis..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection and modulation of IAPs and NAIP for the diagnosis... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3607457